Ventilation heterogeneity is associated with airway responsiveness in asthma but not COPD

Respiratory Physiology and Neurobiology

Volumn 189, Issue 1, 2013, Pages 106-111

  Hardaker, Kate M ^a,b,c   Downie, Sue R ^a,b,c   Kermode, Jessica A ^a,b,c   Berend, Norbert ^a,b,c   King, Gregory G ^a,b,c,d   Salome, Cheryl M ^a,b,c  

^a WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c The Cooperative Research Centre for Asthma and Airways   (Australia)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Aging; Airway hyperresponsiveness; Chronic obstructive pulmonary disease; Physiology; Pulmonary mechanics

Indexed keywords

METHACHOLINE; NITRIC OXIDE;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; LUNG VOLUME; MALE; NITROGEN WASHOUT; PRIORITY JOURNAL; RESIDUAL VOLUME; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT PARAMETERS; SPIROMETRY; VENTILATION HETEROGENEITY;

AGING; AIRWAY HYPERRESPONSIVENESS; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; PHYSIOLOGY; PULMONARY MECHANICS;

AGED; AGED, 80 AND OVER; ASTHMA; BREATH TESTS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; PLETHYSMOGRAPHY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY VENTILATION; SPIROMETRY;

EID: 84881502297     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2013.07.009     Document Type: Article

References (39)

1. American Thoracic S., European Respiratory S. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. American Journal of Respiratory and Critical Care Medicine 2005, 171:912-930.
2. Barisione G., Crimi E., Bartolini S., Saporiti R., Copello F., Pellegrino R., Brusasco V. How to interpret reduced forced expiratory volume in 1s (FEV1)/vital capacity ratio with normal FEV1. European Respiratory Journal 2009, 33:1396-1402.
3. Barnes P.J. Against the Dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases. American Journal of Respiratory and Critical Care Medicine 2006, 174:240-243. discussion 243-244.
4. Cerveri I., Bruschi C., Zoia M.C., Zanon P., Maccarini L., Grassi M., Rampulla C., Cerveri I., Bruschi C., Zoia M.C., Zanon P., Maccarini L., Grassi M., Rampulla C. Distribution of bronchial nonspecific reactivity in the general population. Chest 1988, 93:26-30.
5. Crapo R.O., Casaburi R., Coates A.L., Enright P.L., Hankinson J.L., Irvin C.G., MacIntyre N.R., McKay R.T., Wanger J.S. Guidelines for methacholine and exercise challenge testing-1999. American Journal of Respiratory and Critical Care Medicine 2000, 161:309-329.
6. Crapo R.O., Morris A.H. Standardized single breath normal values for carbon monoxide diffusing capacity. American Review of Respiratory Disease 1981, 123:185-189.
7. Crapo R.O., Morris A.H., Clayton P.O., Nixon C.R. Lung volumes in healthy non-smoking adults. Bulletin Europeen de Physiopathologie Respiratoire 1982, 18:419-425.
8. Cuttitta G., Cibella F., Bellia V., Grassi V., Cossi S., Bucchieri S., Bonsignore G. Changes in FVC during methacholine-induced bronchoconstriction in elderly patients with asthma: bronchial hyperresponsiveness and aging. Chest 2001, 119:1685-1690.
9. Deykin A., Massaro A.F., Drazen J.M., Israel E. Exhaled nitric oxide as a diagnostic test for asthma. Online versus offline techniques and effect of flow rates. American Journal of Respiratory and Critical Care Medicine 2002, 165:1597-1601.
10. Downie S.R., Salome C.M., Verbanck S., Thompson B., Berend N., King G.G. Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation. Thorax 2007, 62:684-689.
11. Gibson P.G., Saltos N., Borgas T. Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma. Journal of Allergy and Clinical Immunology 2000, 105:752-759.
12. Hankinson J.L., Odencrantz J.R., Fedan K.B. Spirometric reference values from a sample of the general U.S. population. American Journal of Respiratory and Critical Care Medicine 1999, 159:179-187.
13. Hardaker K.M., Downie S.R., Kermode J.A., Farah C.S., Brown N.J., Berend N., King G.G., Salome C.M. Predictors of airway hyperresponsiveness differ between old and young patients with asthma. Chest 2011, 139:1395-1401.
14. Hospers J.J., Postma D.S., Rijcken B., Weiss T., Schouten J.P. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet 2000, 1313-1317. 356(9238):1313-7 356.
15. Irvin C.G., Bates J.H. Physiologic dysfunction of the asthmatic lung: what's going on down there, anyway?. Proceedings of the American Thoracic Society 2009, 1(3). 176-83 6, 306-311.
16. Jansons H., Fokkens J.K., Van der Tweel I., Kreukniet J. Re-breathing vs single-breath TLCO in patients with unequal ventilation and diffusion. Respiratory Medicine 1998, 92:18-24.
17. Jatakanon A., Lim S., Kharitonov S.A., Chung K.F., Barnes P.J. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998, 53:91-95.
18. Jones P.W., Quirk F.H., Baveystock C.M., Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's respiratory questionnaire. American Review of Respiratory Disease 1992, 145:1321-1327.
19. Juniper E.F., O'Byrne P.M., Guyatt G.H., Ferrie P.J., King D.R. Development and validation of a questionnaire to measure asthma control. European Respiratory Journal 1999, 14:902-907.
20. Kanner R., Connett J., Altose M., Buist A., Lee W., Tashkin D., Wise R. Gender difference in airway hyperresponsiveness in smokers with mild COPD: the lung health study. American Journal of Respiratory and Critical Care Medicine 1994, 150:956-961.
21. Kraft M. Asthma and chronic obstructive pulmonary disease exhibit common origins in any country. American Journal of Respiratory and Critical Care Medicine 2006, 174:238-240. discussion 243-234.
22. MacIntyre N., Crapo R.O., Viegi G., Johnson D.C., van der Grinten C.P.M., Brusasco V., Burgos F., Casaburi R., Coates A., Enright P., Gustafsson P., Hankinson J., Jensen R., McKay R., Miller M.R., Navajas D., Pedersen O.F., Pellegrino R., Wanger J. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. European Respiratory Journal 2005, 26:720-735.
23. Nelson H.S., Weiss S.T., Bleecker E.R., Yancey S.W., Dorinsky P.M., Grp S.S. The salmeterol multicenter asthma research trial-a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006, 129:15-26.
24. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., Hurd S.S., Committee G.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. American Journal of Respiratory and Critical Care Medicine 2001, 163:1256-1276.
25. Peat J.K., Salome C.M., Berry G., Woolcock A.J. Relation of dose-response slope to respiratory symptoms and lung function in a population study of adults living in Busselton, Western Australia. American Review of Respiratory Disease 1992, 146:860-865.
26. Peat J.K., Woolcock A.J., Cullen K. Rate of decline of lung function in subjects with asthma. European Journal of Respiratory Diseases 1987, 70:171-179.
27. Postma D.S., de Vries K., Koeter G.H., Sluiter H.J. Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. American Review of Respiratory Disease 1986, 134:276-280.
28. Salome C.M., Roberts A.M., Brown N.J., Dermand J., Marks G.B., Woolcock A.J. Exhaled nitric oxide measurements in a population sample of young adults. American Journal of Respiratory and Critical Care Medicine 1999, 159:911-916.
29. Schwartz J., Schindler C., Zemp E., Perruchoud A.P., Zellweger J.P., Wuthrich B., Leuenberger P., Ackermann-Liebrich U. Predictors of methacholine responsiveness in a general population. Chest 2002, 122:812-820.
30. Tashkin D., Altose M., Connett J., Kanner R., Lee W., Wise R. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease: the lung health study research group. American Journal of Respiratory and Critical Care Medicine 1996, 153:1802-1811.
31. Tashkin D.P., Altose M.D., Bleecker E.R., Connett J.E., Kanner R.E., Lee W.W., Wise R. The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation: the lung health study research group. American Review of Respiratory Disease 1992, 145:301-310.
32. Timmins S.C., Diba C., Farrow C.E., Schoeffel R.E., Berend N., Salome C.M., King G.G. The relationship between airflow obstruction, emphysema extent, and small airways function in COPD. Chest 2012, 142:312-319.
33. van den Berge M., Vonk J.M., Gosman M., Lapperre T.S., Snoeck-Stroband J.B., Sterk P.J., Kunz L.I.Z., Hiemstra P.S., Timens W., ten Hacken N.H.T., Kerstjens H.A.M., Postma D.S. Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD. European Respiratory Journal 2012, 40:1098-1105.
34. Venegas J.G., Winkler T., Musch G., Vidal Melo M.F., Layfield D., Tgavalekos N., Fischman A.J., Callahan R.J., Bellani G., Harris R.S. Self-organized patchiness in asthma as a prelude to catastrophic shifts. Nature 2005, 434:777-782.
35. Verbanck S., Schuermans D., Noppen M., Van Muylem A., Paiva M., Vincken W. Evidence of acinar airway involvement in asthma. American Journal of Respiratory and Critical Care Medicine 1999, 159:1545-1550.
36. Verbanck S., Schuermans D., VanMuylem A., Paiva M., Noppen M., Vincken W. Ventilation distribution during histamine provocation. Journal of Applied Physiology 1997, 105(3). 832-8 83, 1907-1916.
37. Verhoeven G.T., Verbraak A.F., Boere-van der Straat S., Hoogsteden H.C., Bogaard J.M. Influence of lung parenchymal destruction on the different indexes of the methacholine dose-response curve in COPD patients. Chest 2000, 117:984-990.
38. Yan K., Salome C., Woolcock A.J. Rapid method for the measurement of bronchial responsiveness. Thorax 1983, 38:760-765.
39. Yan K., Salome C.M., Woolcock A.J. Prevalence and nature of bronchial hyperresponsiveness in subjects with chronic obstructive pulmonary disease. American Review of Respiratory Disease 1985, 132:25-29.